Literature DB >> 13340826

[Comparative research on nucleic acid metabolism and respiratory metabolism of Proteus vulgaris, its stable L-phase and of the pleuropneumonia-like organisms].

O KANDLER, C ZEHENDER, J MULLER.   

Abstract

Entities:  

Keywords:  NUCLEIC ACIDS/metabolism; OXYGEN/metabolism; PLEUROPNEUMONIA-LIKE ORGANISMS/metabolism; PROTEUS VULGARIS/metabolism

Mesh:

Substances:

Year:  1956        PMID: 13340826

Source DB:  PubMed          Journal:  Arch Mikrobiol        ISSN: 0003-9276


× No keyword cloud information.
  9 in total

1.  The effect of various incubation temperatures on the ribonucleic acid production of a mesophilic and thermophilic bacterium.

Authors:  R WELLERSON; P A TETRAULT
Journal:  J Bacteriol       Date:  1955-04       Impact factor: 3.490

2.  [Studies on morphology and multiplication of pleuropneumonia-like organisms and on bacterial L-phase. II. Electron microscopy].

Authors:  G KANDLER; O KANDLER; O HUBER
Journal:  Arch Mikrobiol       Date:  1954

3.  [Studies on morphology and multiplication of pleuropneumonia-like organisms and on bacterial L-phase, I. Light microscopy].

Authors:  G KANDLER; O KANDLER
Journal:  Arch Mikrobiol       Date:  1954

4.  [Obtaining L-forms in Klebsiella pneumoniae in liquid surrounding in a mouse under the action of penicillin].

Authors:  E GRASSET; V BONIFAS
Journal:  Schweiz Z Pathol Bakteriol       Date:  1955

5.  The pleuropneumonia group of organisms: a review, together with some new observations.

Authors:  D G EDWARD
Journal:  J Gen Microbiol       Date:  1954-02

6.  The nucleic acid fractions of a strain of Streptococcus faecalis.

Authors:  H S A SHERRATT; A J THOMAS
Journal:  J Gen Microbiol       Date:  1953-04

7.  THE SYNTHESIS OF NUCLEIC ACIDS IN CULTURES OF ESCHERICHIA COLI, STRAINS B AND B/R.

Authors:  M L Morse; C E Carter
Journal:  J Bacteriol       Date:  1949-09       Impact factor: 3.490

8.  THE DEVELOPMENT OF PROTEUS CULTURES IN THE PRESENCE OF PENICILLIN.

Authors:  L Dienes
Journal:  J Bacteriol       Date:  1949-05       Impact factor: 3.490

9.  The formation and development of large bodies in Proteus vulgaris OX-19. I. Bright phase contrast observations of living bacteria.

Authors:  H STEMPEN; W G HUTCHINSON
Journal:  J Bacteriol       Date:  1951-03       Impact factor: 3.490

  9 in total
  11 in total

Review 1.  COMPARATIVE PHYSIOLOGY OF PLEUROPNEUMONIA-LIKE AND L-TYPE ORGANISMS.

Authors:  P F SMITH
Journal:  Bacteriol Rev       Date:  1964-06

2.  Critical factors influencing growth of L forms of Proteus mirabilis.

Authors:  R A ALTENBERN
Journal:  J Bacteriol       Date:  1961-04       Impact factor: 3.490

Review 3.  MYCOPLASMA SPECIES OF MAN.

Authors:  L HAYFLICK; R M CHANOCK
Journal:  Bacteriol Rev       Date:  1965-06

4.  Growth of bacterial L forms and bacterial protoplasts.

Authors:  C WEIBULL; H BECKMAN
Journal:  J Bacteriol       Date:  1960-05       Impact factor: 3.490

5.  [Nucleic acid & phosphate metabolism in normal & inhibited forms of proteus vulgaris Hauser].

Authors:  E PETRAS
Journal:  Arch Mikrobiol       Date:  1958

6.  [A simple method for isolating membrane ground substance from gram-positive & gram-negative bacteria].

Authors:  O KANDLER; A HUND; C ZEHENDER
Journal:  Arch Mikrobiol       Date:  1958

7.  Quantitative conversion of cells and protoplasts of Proteus mirabilis and Escherichia coli to the L-form.

Authors:  O E LANDMAN; R A ALTENBERN; H S GINOZA
Journal:  J Bacteriol       Date:  1958-05       Impact factor: 3.490

8.  Nucleic acid content of pleuropneumonialike organisms from human sources.

Authors:  R J LYNN; P F SMITH
Journal:  J Bacteriol       Date:  1957-12       Impact factor: 3.490

9.  [On the fine structure of chromosomes. I. On the cytology of Escherichia coli. B. Cell growth, importance of electronoptic findings].

Authors:  F W SCHLOTE
Journal:  Arch Mikrobiol       Date:  1961

10.  Occurrence of catalase in pleuropneumonia-like organisms and bacterial L forms.

Authors:  C WEIBULL; K HAMMARBERG
Journal:  J Bacteriol       Date:  1962-09       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.